New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New radiopharmaceutical shows promise for improved detection of neuroendocrine tumors

New radiopharmaceutical shows promise for improved detection of neuroendocrine tumors

by Society of Nuclear Medicine and Molecular ImagingRepresentative maximum-intensity projection from PET/CT scans comparing [55Co]Co-DOTATATE (A–C), [64Cu]Cu-DOTATATE (D–F), and [68Ga]Ga-DOTATATE (G).
World medicine December 11,2023
New radiopharmaceutical shows promise for improved detection of neuroendocrine tumors

New radiopharmaceutical shows promise for improved detection of neuroendocrine tumors

by Society of Nuclear Medicine and Molecular ImagingRepresentative maximum-intensity projection from PET/CT scans comparing [55Co]Co-DOTATATE (A–C), [64Cu]Cu-DOTATATE (D–F), and [68Ga]Ga-DOTATATE (G).
World medicine December 11,2023
Mapping genetic variants driving toxicity to leukemia therapy

Mapping genetic variants driving toxicity to leukemia therapy

bySt. Jude Children's Research HospitalJun Yang and his paper co-authors have created an extensive map of NUDT15 variants to more accurately predict toxicity from the critical cancer drugs t
World medicine December 11,2023
Mapping genetic variants driving toxicity to leukemia therapy

Mapping genetic variants driving toxicity to leukemia therapy

bySt. Jude Children's Research HospitalJun Yang and his paper co-authors have created an extensive map of NUDT15 variants to more accurately predict toxicity from the critical cancer drugs t
World medicine December 11,2023
Scientists reveal new details of cellular process that prevents spread of cancer

Scientists reveal new details of cellular process that prevents spread of cancer

by UK Research and InnovationSchematic showing the pore forming reorganization of the mitochondrial surface by Bax during the initial stages of apoptosis determined from this study. Credit: Luke Clift
World medicine December 11,2023
Scientists reveal new details of cellular process that prevents spread of cancer

Scientists reveal new details of cellular process that prevents spread of cancer

by UK Research and InnovationSchematic showing the pore forming reorganization of the mitochondrial surface by Bax during the initial stages of apoptosis determined from this study. Credit: Luke Clift
World medicine December 11,2023
Genetic test could pick out 'ultra high risk' bone marrow cancer patients

Genetic test could pick out 'ultra high risk' bone marrow cancer patients

byInstitute of Cancer ResearchCredit: CC0 Public DomainA new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at 'ultra high risk' o
World medicine December 11,2023
Genetic test could pick out 'ultra high risk' bone marrow cancer patients

Genetic test could pick out 'ultra high risk' bone marrow cancer patients

byInstitute of Cancer ResearchCredit: CC0 Public DomainA new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at 'ultra high risk' o
World medicine December 11,2023
Blood test can predict clinical response to immunotherapy in metastatic NSCLC

Blood test can predict clinical response to immunotherapy in metastatic NSCLC

byPerelman School of Medicine at the University of PennsylvaniaBlood test can predict clinical response to immunotherapy in metastatic non-small cell lung cancer. Credit: Penn MedicineNon-small
World medicine December 11,2023
Blood test can predict clinical response to immunotherapy in metastatic NSCLC

Blood test can predict clinical response to immunotherapy in metastatic NSCLC

byPerelman School of Medicine at the University of PennsylvaniaBlood test can predict clinical response to immunotherapy in metastatic non-small cell lung cancer. Credit: Penn MedicineNon-small
World medicine December 11,2023
Older women with breast cancer may benefit from genetic testing, study suggests

Older women with breast cancer may benefit from genetic testing, study suggests

byStanford University Medical CenterCredit: CC0 Public DomainAbout 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA
World medicine December 11,2023
Older women with breast cancer may benefit from genetic testing, study suggests

Older women with breast cancer may benefit from genetic testing, study suggests

byStanford University Medical CenterCredit: CC0 Public DomainAbout 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA
World medicine December 11,2023
Cancer death rates continue to fall in U.S., report says

Cancer death rates continue to fall in U.S., report says

(HealthDay)—U.S. death rates from cancer continued falling from 2001 to 2017—dropping an average 1.5% a year, a new report shows.The annual decline was slightly larger among men (1.8%) than women (1.4
World medicine December 11,2023
Cancer death rates continue to fall in U.S., report says

Cancer death rates continue to fall in U.S., report says

(HealthDay)—U.S. death rates from cancer continued falling from 2001 to 2017—dropping an average 1.5% a year, a new report shows.The annual decline was slightly larger among men (1.8%) than women (1.4
World medicine December 11,2023
Surveillance after surgery does not improve outcomes for patients with glioblastoma

Surveillance after surgery does not improve outcomes for patients with glioblastoma

byUniversity of MissouriN. Scott Litofsky, M.D. Credit: MU Health CareGlioblastoma is an aggressive and deadly brain cancer. Although improved treatment protocols have doubled the survival rate
World medicine December 11,2023
Surveillance after surgery does not improve outcomes for patients with glioblastoma

Surveillance after surgery does not improve outcomes for patients with glioblastoma

byUniversity of MissouriN. Scott Litofsky, M.D. Credit: MU Health CareGlioblastoma is an aggressive and deadly brain cancer. Although improved treatment protocols have doubled the survival rate
World medicine December 11,2023
A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

byThe Spanish National Cancer Research CentrePancreatic adenocarcinoma tumor cells showing signs of damage in the DNA of the nucleus (white dots) and micronuclei (in green), after treatment with
World medicine December 11,2023
A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

byThe Spanish National Cancer Research CentrePancreatic adenocarcinoma tumor cells showing signs of damage in the DNA of the nucleus (white dots) and micronuclei (in green), after treatment with
World medicine December 11,2023
Chemotherapy after surgery halves risk of rare kidney cancer coming back

Chemotherapy after surgery halves risk of rare kidney cancer coming back

by Sarah Wells,Institute of Cancer ResearchCredit: CC0 Public DomainChemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in th
World medicine December 11,2023
Chemotherapy after surgery halves risk of rare kidney cancer coming back

Chemotherapy after surgery halves risk of rare kidney cancer coming back

by Sarah Wells,Institute of Cancer ResearchCredit: CC0 Public DomainChemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in th
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com